iiinova — where your digital self keeps evolving

TRIMTECH Therapeutics @trimtechtx.bsky.social · 28/09/2026

Join our team of world-renowned scientists who are working to create a differentiated portfolio of potent, highly specific targeted protein degraders for the treatment of CNS and inflammatory disorders. ➡️Associate Director (Biology) ➡️Scientist (Molecular & Cell Biology) shorturl.at/WqfQo

000

TRIMTECH Therapeutics @trimtechtx.bsky.social · 24/09/2026

Friday 25th September our team will be in London for WuXi AppTec's SerenTPDy 2026. Schedule a meeting with Damian and Andrea 📩 trimtechtherapeutics.com/contact/

000

TRIMTECH Therapeutics @trimtechtx.bsky.social · 21/09/2026

September is World Alzheimer’s Month. To learn more and how you can get involved ➡️https://www.alzint.org/ At TRIMTECH, we are developing first-in-class medicines to address the critical need for cost-effective, disease modifying treatments for neurodegenerative disorders ➡️https://shorturl.at/YDHfU

000

TRIMTECH Therapeutics @trimtechtx.bsky.social · 18/09/2026

🏆Delighted to share that we were awarded ‘Cambridge Judge Graduate Business of the Year’ at this week's Business Weekly Awards!

000

TRIMTECH Therapeutics @trimtechtx.bsky.social · 15/09/2026

SVP & Head of Chemistry Alex Alanine will be at Discovery on Target in Boston. Alex will discuss our approach to neurodegenerative disease, harnessing TRIM21 to selectively target toxic protein aggregates. Get in touch to schedule a meeting: trimtechtherapeutics.com/contact/

000

TRIMTECH Therapeutics @trimtechtx.bsky.social · 08/09/2026

Our CEO Nicki Thompson has been selected as a finalist in two categories for this year’s European Lifestars Awards: 🏆 Women-Led Business of the Year 🏆 CEO of the Year Full finalist roster: informaconnect.com/european-lif... #lifestarsawards

000

TRIMTECH Therapeutics @trimtechtx.bsky.social · 01/09/2026

CEO Nicki Thompson will be in Boston on 9-10 September for the Oncology & Immunology Innovation Partnering & Licensing Summit. Nicki will join a panel discussing strategies for navigating BD engagements at the seed stage. Get in touch to schedule a meeting: trimtechtherapeutics.com/contact/

000

TRIMTECH Therapeutics @trimtechtx.bsky.social · 25/08/2026

CEO Nicki Thompson will be in Oxford for the annual translational research conference “From the Laboratory to the Clinic: Complex Pathogenesis of Disease”. See below for details of her talk ⬇️

000

TRIMTECH Therapeutics @trimtechtx.bsky.social · 17/08/2026

Missed our CEO's presentation at the Accelerating Bio-Innovation (ABI) Conference earlier this year? The recording of her talk, "Expanding the Degrader Toolbox for Neuro Applications", is now available to watch on our website: shorturl.at/2HsUE

000

TRIMTECH Therapeutics @trimtechtx.bsky.social · 09/07/2026

Starting this Sunday, our team will be at #AAIC26 in London. TRIMTECH is looking forward to a week of scientific sessions, presentations, and networking at the largest international conference dedicated to dementia science. Schedule a meeting 📩 trimtechtherapeutics.com/contact/

000

TRIMTECH Therapeutics @trimtechtx.bsky.social · 23/06/2026

Delighted to announce increasing our total seed round to $47M, with an additional $14M investment to support further development of our targeted protein degrader portfolio. Read more: shorturl.at/DfaXn

021

TRIMTECH Therapeutics @trimtechtx.bsky.social · 22/06/2026

On Thursday 25 June, Andrea Testa and Dean Clift will be in Maine presenting at the Gordon Research Conference on Induced Proximity Modalities and Therapeutics. See below for more details ⬇️

011

TRIMTECH Therapeutics @trimtechtx.bsky.social · 12/06/2026

This Pride Month, and especially with #CambridgePride this weekend, we at TRIMTECH Therapeutics are proud to stand with the LGBTQ+ community.

000

TRIMTECH Therapeutics @trimtechtx.bsky.social · 05/06/2026

On June 10th, Co-Founder and Head of Research Damian Crowther will be at the Oxford Science Park for the Creative Disruption Forum on the Future of Neuro Therapeutics and Innovations. See below for session details ⬇️

000

TRIMTECH Therapeutics @trimtechtx.bsky.social · 12/05/2026

CEO Nicki Thompson will join ‘The 2026 Biotech Playbook’ panel at One Nucleus' BioBeat event on Thursday 14th May.

020

TRIMTECH Therapeutics @trimtechtx.bsky.social · 08/05/2026

We’re delighted that TRIMTECH Therapeutics won 'Start-Up of the Year' at the 2026 Cambridge Independent Science & Technology Awards! Huge thanks to our team and supporters for helping drive our mission forward. Read more: lnkd.in/dJmmd_6S

011

TRIMTECH Therapeutics @trimtechtx.bsky.social · 27/04/2026

Our Co-Founder and Head of Research Damian Crowther will be presenting at Magdalene College for Dementia Research Day on Tuesday. See below for details ⬇️

010

TRIMTECH Therapeutics @trimtechtx.bsky.social · 21/04/2026

Our CEO Nicki Thompson will be joining the "Partnering with Big Pharma" panel at AngloNordic Life Science Conference XXII in London on Thursday. Reach out if you’d like to meet 📩 trimtechtherapeutics.com/contact/

011

TRIMTECH Therapeutics @trimtechtx.bsky.social · 17/04/2026

Our CEO Nicki Thompson is presenting at the Accelerating Bio-Innovation (ABI) Conference in Cambridge next week (20–22 April). Get in touch if you're attending 📩 trimtechtherapeutics.com/contact/

000

TRIMTECH Therapeutics @trimtechtx.bsky.social · 24/03/2026

We’re delighted to be shortlisted for this year’s Cambridge Independent Science & Technology Awards, in the 'Start-up of the Year' category. Congratulations to all finalists – we’re looking forward to joining everyone at Hinxton Hall on 7th May for the awards ceremony! More: shorturl.at/QCEKK

010

TRIMTECH Therapeutics @trimtechtx.bsky.social · 16/03/2026

This week Damian and Jennie will be attending AD/PD 2026 in Copenhagen for the international conference on Alzheimer's and Parkinson's diseases and related neurological disorders. Stop by our poster presentations to learn more about TRIMTECH’s scientific approach ⬇️

001

TRIMTECH Therapeutics @trimtechtx.bsky.social · 05/03/2026

Our Co-Founder and Head of Research Damian Crowther will be presenting at the 6th Annual TPD & Induced Proximity Summit Europe. Schedule a meeting 📩 trimtechtherapeutics.com/contact/

000

TRIMTECH Therapeutics @trimtechtx.bsky.social · 26/02/2026

Our CEO, Nicki Thompson, will be in Zurich on 3rd March for the Sachs European Neuroscience Innovation Forum, part of the Sachs Spring Life Sciences Week. Nicki will join the Alzheimer's Disease & Dementia Panel (9:40 AM CET) to discuss the latest progress in drug development.

000

TRIMTECH Therapeutics @trimtechtx.bsky.social · 19/02/2026

Our Associate Director, Jennie Gold, will be presenting at the CDD European Life Science Community Meeting. Catch her presentation in the afternoon to learn more about our approach to combat neurodegenerative diseases ⬇️

000

TRIMTECH Therapeutics @trimtechtx.bsky.social · 17/02/2026

Meet our Co-founder and Chief Scientific Adviser Dr Leo James, FRS, and learn how his discovery of TRIM21 underpins TRIMTECH’s approach to developing small molecule targeted protein degraders: trimtechtherapeutics.com/meet-the-tea...

000

TRIMTECH Therapeutics @trimtechtx.bsky.social · 11/02/2026

Today is the International Day of Women and Girls in Science, observed each year on February 11. At TRIMTECH, we’re proud that our team includes so many talented women scientists at all levels of the organisation whose expertise, dedication, and impact drive our work forward every day.

000

TRIMTECH Therapeutics @trimtechtx.bsky.social · 10/02/2026

We have been shortlisted for the One Nucleus Awards 2026, in the ‘Best Therapeutic R&D Programme of the Year’ category! Visit our website to learn more about our work: trimtechtherapeutics.com/science/

010

TRIMTECH Therapeutics @trimtechtx.bsky.social · 20/01/2026

Join TRIMTECH Scientist, Jonathan Benn, at the next Cambridge New Therapeutics Forum and learn more about our aggregate-selective targeted protein degrader programme, offering a small molecule approach to combat neurodegenerative diseases. Register here: www.eventbrite.co.uk/e/advances-i...

000

TRIMTECH Therapeutics @trimtechtx.bsky.social · 14/01/2026

JPM Healthcare Conference Week 2026 is well underway in San Francisco! Our CEO Nicki Thompson presented at the Cambridge x London Life Sciences Showcase, part of RESI JPM Healthcare Week 2026.

000

TRIMTECH Therapeutics @trimtechtx.bsky.social · 06/01/2026

Happy New Year! We’re kicking off 2026 in San Francisco at Sachs’ 9th Annual Neuroscience Innovation Forum and JPM Healthcare Conference Week. Schedule a meeting 📩 trimtechtherapeutics.com/contact/

010

TRIMTECH Therapeutics @trimtechtx.bsky.social · 19/12/2025

From all of us at TRIMTECH, happy holidays! 🎄 We’re incredibly proud of what our team has achieved and look forward to another exciting year ahead!

000

TRIMTECH Therapeutics @trimtechtx.bsky.social · 02/12/2025

Delighted to welcome Alison Lawton as Chair of our Board. With 35+ years in global biotech and pharma, she brings deep development, operational and leadership experience to support TRIMTECH’s next stage of growth: shorturl.at/xXXbC

020

TRIMTECH Therapeutics @trimtechtx.bsky.social · 28/11/2025

Our academic co-founders have published in Nature Communications - detailing the science behind TRIMTECH’s TRIMTAC® degraders. Congrats to Will, Leo, Dean, Jonathan, and all collaborators advancing state-selective protein degradation: www.nature.com/articles/s41...

000

TRIMTECH Therapeutics @trimtechtx.bsky.social · 18/11/2025

We’re absolutely delighted to have been awarded ‘Seed Raise of the Year’ at last night’s LSX European Lifestars Awards!

000

TRIMTECH Therapeutics @trimtechtx.bsky.social · 13/11/2025

Our team will be in London during Jefferies Global Healthcare Conference Week, kicking off discussions across the global healthcare sector as part of London Life Sciences Week!

000

TRIMTECH Therapeutics @trimtechtx.bsky.social · 11/11/2025

We’re delighted to welcome Dr. Mike Hutton to our SAB! Mike joins Prof. Alessio Ciulli FRS and Dr. Adam Gilbert in advancing our mission to develop novel therapeutics that target protein aggregates in neurodegenerative diseases. Read more: trimtechtherapeutics.com/trimtech-the...

000

TRIMTECH Therapeutics @trimtechtx.bsky.social · 05/11/2025

Meet our Senior Director of Chemistry, Dr Andrea Testa, and discover his journey in targeted protein degradation research in this blog: trimtechtherapeutics.com/meet-the-tea...

001

TRIMTECH Therapeutics @trimtechtx.bsky.social · 04/11/2025

We’ll be in Barcelona for the 2nd Annual Drug Discovery Chemistry Europe. Catch our Head of Exploratory Biology, Dr Dean Clift, on Day 1 in the Next-Gen Degraders & Molecular Glues track ➡️https://www.drugdiscoverychemistry.com/europe/degraders-molecular-glues

000

TRIMTECH Therapeutics @trimtechtx.bsky.social · 30/10/2025

CEO Dr Nicki Thompson is in Boston for the 8th Annual TPD and Induced Proximity Summit. Catch her sessions today to learn more about TRIMTECH’s work in TPD.

010

TRIMTECH Therapeutics @trimtechtx.bsky.social · 30/10/2025

We’ve been awarded ‘Start-up of the Year’ at the annual TPD & Induced Proximity Awards 🏆 Learn more about our pipeline of small-molecule, aggregate-selective, targeted protein degraders for the treatment of neurodegenerative diseases: trimtechtherapeutics.com/science/

010

TRIMTECH Therapeutics @trimtechtx.bsky.social · 16/10/2025

Only a few weeks to go until the 8th Annual TPD and Induced Proximity Summit! Learn more about our pipeline of small-molecule, aggregate-selective, targeted protein degraders for the treatment of neurodegenerative diseases: trimtechtherapeutics.com/science/

010

TRIMTECH Therapeutics @trimtechtx.bsky.social · 07/10/2025

Dr Damian Crowther, Head of Research, will be at Alzheimer’s Research UK’s Drug Discovery Alliance Networking Event, giving the plenary session on ‘Drug Discovery and the Future of Drug Development’. Learn more: www.alzheimersresearchuk.org/about-us/how...

010

TRIMTECH Therapeutics @trimtechtx.bsky.social · 25/09/2025

Our CEO, Nicki Thompson, participated in a panel discussion on ‘Innovations in Protein Degradation in the Biotech Sector’ at Discovery on Target in Boston, highlighting how novel degrader modalities are driving innovation and enabling pursuit of challenging targets. #BostonDOT #TPD

040

TRIMTECH Therapeutics @trimtechtx.bsky.social · 22/09/2025

We’re incredibly proud to be one of Fierce Biotech’s #Fierce15 – testament to our approach and the milestones our team has already achieved! Our goal is to develop cost-effective, disease-modifying treatments for common, aggregation-driven diseases. More: shorturl.at/IRTJO

000

TRIMTECH Therapeutics @trimtechtx.bsky.social · 19/09/2025

21 Sep is #WorldAlzheimersDay, part of #WorldAlzheimersMonth. Over 55M people live with dementias, yet the need for cost-effective, disease-modifying treatments remains critical. TRIMTECH is advancing small molecule, aggregate-selective, targeted protein degraders 👉 trimtechtherapeutics.com

000

TRIMTECH Therapeutics @trimtechtx.bsky.social · 18/09/2025

Next week our CEO Nicki Thompson will be in Boston for Discovery on Target. Arrange a meeting: trimtechtherapeutics.com/contact/ #BostonDOT

020

TRIMTECH Therapeutics @trimtechtx.bsky.social · 12/09/2025

A busy couple of weeks ahead for the TRIMTECH team – scroll through to see where we’ll be this September ➡️

000

TRIMTECH Therapeutics @trimtechtx.bsky.social · 04/09/2025

EFMC-ASMC 2025 is well underway in Portugal! Join Senior Director of Chemistry, Dr Andrea Testa, at the 12th EFMC Young Medicinal Chemists’ Symposium, organised with the Young Scientist Network. Get in touch ➡️ trimtechtherapeutics.com/contact/

010

TRIMTECH Therapeutics @trimtechtx.bsky.social · 03/09/2025

We’ve been selected as a finalist for ‘Seed Raise of the Year’ at the LSX European Lifestars Awards. Earlier this year we closed a $31M (£25M) seed round, to support development of our protein degrader pipeline ➡️ informaconnect.com/european-lif...

010

TRIMTECH Therapeutics @trimtechtx.bsky.social · 02/09/2025

Excited to introduce our SAB! Professor Alessio Ciulli (SAB Chair) and Dr Adam Gilbert. Both are global leaders in targeted protein degradation, providing strategic guidance to advance our TRIMTAC and TRIMGLUE degraders and small molecule therapeutic pipeline. More: shorturl.at/f76pR

020